Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
12 Leser
Artikel bewerten:
(0)

Abbott Introduces New Similac Breastfeeding Supplement with DHA, Lutein and Vitamin E

ABBOTT PARK, Ill., July 24, 2014 /PRNewswire/ -- Nutrition needs are greater when breastfeeding than any other time in a woman's life, including pregnancy, yet new research reveals diet alone may not be enough to meet the high nutritional needs during this important time for mom and baby.[1]

Abbott (NYSE: ABT), the makers of Similac® and experts in infant nutrition for nearly 90 years, studied the diets of more than 80 lactating women to assess how their nutritional intake compared to dietary recommendations. The research found few lactating women consistently consume enough key nutrients, like DHA, lutein and vitamin E, through their diet.

Abbott's new Similac Breastfeeding Supplement is specially designed to enhance the levels of DHA, lutein and vitamin E in breast milk. These key nutrients are important for nourishing baby's brain and eyes during this critical time of development*. The supplement should be taken with a prenatal vitamin or multivitamin to help fill moms' dietary gaps.

-³Moms are first encouraged to focus on food to obtain ideal nutrition,-³ said Christina Sherry, Abbott Research Scientist who led the study. -³But as demonstrated by our study, the reality is that many women find it difficult to eat a well-balanced diet while adjusting to caring for a newborn. And even though many women may continue to take a prenatal vitamin during this time, many prenatal vitamins do not have, or have enough, DHA, lutein and vitamin E.-³

As an example, to achieve the desired levels of DHA, lutein and vitamin E in their diets, women would need to eat four 3 ounce servings of salmon a week as a source of DHA, 1 ounce of almonds or peanuts a day as a source of vitamin E and 2 cups of cooked broccoli a day as a source of lutein. In the study, only one out of 10 breastfeeding moms on average got 100 percent of the desired levels for DHA, lutein and vitamin E from their diet.1 Only two moms in the study came close to consuming desired levels of lutein and they consistently reported eating about 2 cups of leafy greens and vegetables almost every day.1

Furthermore, nutrient intake data from the National Health and Nutrition Examination Survey shows that the average diet of women who are child-bearing age is at least 50 percent below the desirable levels of DHA, lutein and vitamin E. The Similac Breastfeeding Supplement contains levels of these important nutrients that are desired in moms' diets. The clinical evidence showed moms who took one Similac Breastfeeding Supplement a day had increased levels of DHA, lutein and vitamin E in their breast milk compared to mothers who did not take the supplement.

As noted in The Journal of Nutrition published in June, given -³the importance of lutein as an antioxidant and in eye health, it is prudent that lactating women consume adequate lutein from the diet or supplements to ensure adequate concentrations in breast milk for infant growth and development.-³[2]

Additional research in a 2010 report in the Journal of Pediatrics showed that children whose mothers received modest amounts of DHA during the first four months of breastfeeding performed better on a test of sustained attention.[3] DHA, which helps support baby's brain development*, is highly susceptible to damage from oxidation and vitamin E protects important fatty acids, like DHA, from oxidation.

The Similac Breastfeeding Supplement, available at Babies-³R-³Us, contains a 30-day supply (30 softgels) and costs $9.99. For more information, visit www.Similac.com.

About Similac
Similac offers a complete line of infant formulas, specialty products for preterm babies, the Similac Prenatal Vitamin and the Similac Breastfeeding Supplement. With a well-documented heritage of innovation, Similac formulas have been developed with leading scientists and more than 280 clinical studies.

About Abbott
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 69,000 people.

Visit Abbott at www.Abbott.com and connect with us on Twitter at @AbbottNews.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

[1] FASEB J April 2014 28 (Supplement 1):810.1

[2] Sherry, C. L., et al. "Lutein Supplementation Increases Breast Milk and Plasma Lutein Concentrations in Lactating Women and in Infant Plasma Concentrations but Does Not Affect Other Carotenoids." J Nutr (2014)

[3] Jensen, C. L., et al. "Effects of Early Maternal Docosahexaenoic Acid Intake on Neuropsychological Status and Visual Acuity at Five Years of Age of Breast-Fed Term Infants." J Pediatr 157.6 (2010): 900-5

SOURCE Abbott

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.